Mark Dearden is an experienced life science executive, board member, angel investor, and advisor/mentor. Currently serving as the President and CEO of Specac Ltd, Dearden also holds positions with England Lacrosse, Manchester Angels, Qincade, and DeciBio, while advising Imperagen. They have a proven track record of aligning shareholders, driving M&A strategies, and fostering high-growth technology businesses in the UK. Dearden earned their degree from the University of Warwick - Warwick Business School between 2006 and 2009.
This person is not in the org chart
This person is not in any teams
This person is not in any offices